What is the Role of Palliative Care in Myotonic Dystrophy?
At a Glance
Palliative care for myotonic dystrophy is a specialized medical approach that works alongside your regular treatments to manage daily symptoms like pain and fatigue. Unlike hospice, it can be started at any time after diagnosis to improve your quality of life and help you navigate medical decisions.
In this answer
3 sections
When your doctor suggests palliative care, it is completely normal to feel scared or confused. Many people mistakenly believe the term means they are dying or giving up hope. However, palliative care is simply adding a specialist team to focus entirely on managing your daily symptoms, reducing your physical and emotional stress, and improving your overall quality of life [1][2]. It is a proactive approach that works alongside your ongoing medical treatments [3][4], ensuring you live as comfortably and fully as possible from the time of diagnosis onward.
The Difference Between Palliative Care and Hospice
The stigma around palliative care often comes from confusing it with hospice [5][6]. While both share the goal of maximizing your comfort, they are used at very different stages of life:
- Hospice care is a specific type of palliative care reserved for the very end of life, typically when medical treatments aimed at prolonging life are stopped [7][8].
- Palliative care can and should be started at any stage of a serious illness. You do not have to give up any of your regular treatments or doctor visits to receive it [3][9]. In fact, integrating it early can improve your symptom management, communication with doctors, and overall well-being [10][11].
Because of the stigma attached to the word “palliative,” some doctors may refer to this approach as “supportive care,” but the goal is exactly the same [5].
How Palliative Care Helps with Myotonic Dystrophy
Myotonic dystrophy is a multisystemic condition, meaning it affects many different parts of the body—such as the heart, lungs, and stomach—not just the muscles [12][13]. While your neurologist or cardiologist focuses on monitoring and treating the disease in your organs, a palliative care team focuses on how the disease impacts you and your daily life.
1. Managing Daily Symptoms Early On
You do not have to wait until your disease is advanced to benefit from palliative care. Early in your diagnosis, palliative specialists can act as experts in managing the “invisible” symptoms that make getting through the day difficult. They can help address chronic pain, severe fatigue, excessive daytime sleepiness, and gastrointestinal distress [14][15][16]. Addressing these often-overlooked symptoms can significantly improve your daily functioning [17][18].
2. Navigating Complex Decisions
As DM progresses, you and your family may face complex choices about your medical care. While not everyone will need these interventions, some patients must decide when to start using a breathing aid like a BiPAP machine (a device that helps you breathe while sleeping) or a feeding tube if swallowing becomes unsafe [19][20]. Palliative care teams help you weigh the pros and cons of these interventions, ensuring the choices you make align with your personal values and goals for your life [21][22].
3. Advance Care Planning
Because DM carries risks for severe complications later in life, such as cardiac arrhythmias (irregular heartbeats) or respiratory weakness, it is crucial to plan ahead [23][24]. A palliative care team can gently guide you through advance care planning [25][26]. This means documenting your healthcare wishes now, so your family and doctors know exactly how to care for you in the future if you cannot speak for yourself.
4. Supporting Your Mental Health and Your Family
Because DM is a genetic condition, families often have multiple affected members at once—such as a parent with DM caring for a child who also has the disease. Palliative care teams often include social workers, chaplains, and counselors who understand this profound, multi-generational family burden. They provide emotional support for both you and your loved ones, addressing the anxiety, depression, and caregiver burnout that frequently accompany the disease [27][28].
How to Access Palliative Care
If you are interested in exploring palliative care, here is what you need to know about getting started:
- Ask for a Referral: You can ask your neurologist or primary care doctor for a referral to a palliative care or supportive care specialist [29].
- Where It Happens: Palliative care is flexible. Depending on your local healthcare system, you might see the team in a specialized clinic, during a hospital stay, or even in your own home. Because patients with DM often experience severe fatigue and mobility issues, many palliative care teams also offer telehealth appointments to reduce the burden of travel [30].
- Insurance Coverage: Palliative care consultations are medical specialist visits. Like seeing a cardiologist or neurologist, palliative care is generally covered by Medicare, Medicaid, and most private health insurance plans.
Navigating the healthcare system with DM can feel like a full-time job. Integrated palliative care acts as the “glue” between your various specialists [31][29]. Research shows that involving a palliative team helps reduce unnecessary hospital visits and ensures that your medical care remains focused on what matters most to you [30][32].
Common questions in this guide
What is the difference between palliative care and hospice?
Can I receive palliative care while still treating my myotonic dystrophy?
What specific myotonic dystrophy symptoms can palliative care help with?
How do I get a referral for palliative care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Do you work with a palliative care or supportive care team that has experience with neuromuscular diseases like myotonic dystrophy?
- 2.Which of my current symptoms—such as fatigue, pain, or stomach issues—could a palliative care specialist help me manage right now?
- 3.What is the process for getting a referral to a palliative care specialist, and will they coordinate directly with my neurology and cardiology teams?
- 4.Are telehealth options available for palliative care appointments so I don't have to add another exhausting in-person visit to my schedule?
- 5.When is the right time for us to start discussing advance care planning and the potential future use of interventions like a BiPAP machine?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (32)
- 1
The Development of Pathways in Palliative Medicine: Definition, Models, Cost and Quality Impact.
Finn L, Malhotra S
Healthcare (Basel, Switzerland) 2019; (7(1)) doi:10.3390/healthcare7010022.
PMID: 30717281 - 2
Hospice care in India: A review.
Shukla R, Singh N, Acharya S, Shukla S
Journal of family medicine and primary care 2022; (11(9)):4987-4990 doi:10.4103/jfmpc.jfmpc_2265_21.
PMID: 36505549 - 3
Palliation, end-of-life care and burns; concepts, decision-making and communication - A narrative review.
den Hollander D, Albertyn R, Amber J
African journal of emergency medicine : Revue africaine de la medecine d'urgence 2020; (10(2)):95-98 doi:10.1016/j.afjem.2020.01.003.
PMID: 32612916 - 4
A Trial of Concurrent Care: Shedding Light on the Gray Zone.
Hargadon A, Tran Q, Stephen K, Homler H
Journal of palliative medicine 2017; (20(2)):207-210 doi:10.1089/jpm.2016.0279.
PMID: 28056185 - 5
Haematologists and palliative care: a multicentric qualitative study.
Tricou C, Munier S, Phan-Hoang N, et al.
BMJ supportive & palliative care 2022; (12(e6)):e798-e802 doi:10.1136/bmjspcare-2018-001714.
PMID: 30808629 - 6
Public perception of palliative care: a survey of the general population.
Fliedner MC, Zambrano SC, Eychmueller S
Palliative care and social practice 2021; (15()):26323524211017546 doi:10.1177/26323524211017546.
PMID: 34164622 - 7
The Hidden Curriculum Of Hospice: Die Fast, Not Slow.
Harrison KL
Health affairs (Project Hope) 2021; (40(5)):844-847 doi:10.1377/hlthaff.2021.00259.
PMID: 33939517 - 8
An Evolutionary Concept Analysis of Palliative Care in Oncology Care.
Akoo C, McMillan K
ANS. Advances in nursing science 2023; (46(2)):199-209 doi:10.1097/ANS.0000000000000444.
PMID: 36006006 - 9
Patients with haematological malignancies should not have to choose between transfusions and hospice care.
Odejide OO, Steensma DP
The Lancet. Haematology 2020; (7(5)):e418-e424 doi:10.1016/S2352-3026(20)30042-9.
PMID: 32359453 - 10
Timing and outcomes of outpatient palliative care consultations in advanced cancer.
Torres-Tenor JL, Bruera E, Ortí-Hortelano MJ, et al.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; doi:10.1007/s12094-026-04276-x.
PMID: 41758445 - 11
Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial.
Ma J, Chi S, Buettner B, et al.
Critical care medicine 2019; (47(12)):1707-1715 doi:10.1097/CCM.0000000000004016.
PMID: 31609772 - 12
Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.
Sharp L, Cox DC, Cooper TA
Muscle & nerve 2019; (60(6)):779-789 doi:10.1002/mus.26709.
PMID: 31509256 - 13
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, et al.
Neurologia 2020; (35(3)):185-206 doi:10.1016/j.nrl.2019.01.001.
PMID: 31003788 - 14
Small and large fiber neuropathy in adults with myotonic dystrophy type 1.
Solbakken G, Løseth S, Frich JC, et al.
Frontiers in neurology 2024; (15()):1375218 doi:10.3389/fneur.2024.1375218.
PMID: 38504800 - 15
Health-related quality of life, pain, and fatigue in myotonic dystrophy type 2: a 13-year follow-up study.
Damen MJ, Mul K, van Engelen BGM, et al.
Disability and rehabilitation 2025; 1-8 doi:10.1080/09638288.2025.2571068.
PMID: 41173243 - 16
Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
Laberge L, Gallais B, Auclair J, et al.
Journal of neurology 2020; (267(2)):461-468 doi:10.1007/s00415-019-09592-7.
PMID: 31673761 - 17
Qualitative and Quantitative Aspects of Pain in Patients With Myotonic Dystrophy Type 2.
van Vliet J, Tieleman AA, Verrips A, et al.
The journal of pain 2018; (19(8)):920-930 doi:10.1016/j.jpain.2018.03.006.
PMID: 29601898 - 18
Multidimensional aspects of pain in myotonic dystrophies.
Peric M, Peric S, Rapajic N, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2015; (34(2-3)):126-32.
PMID: 27199540 - 19
Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network.
Russo V, Antonini G, Massa R, et al.
Journal of cardiovascular development and disease 2024; (11(2)) doi:10.3390/jcdd11020063.
PMID: 38392277 - 20
A Greek National Cross-Sectional Study on Myotonic Dystrophies.
Papadimas GK, Papadopoulos C, Kekou K, et al.
International journal of molecular sciences 2022; (23(24)) doi:10.3390/ijms232415507.
PMID: 36555146 - 21
Myotonic Dystrophy.
Hamel JI
Continuum (Minneapolis, Minn.) 2022; (28(6)):1715-1734 doi:10.1212/CON.0000000000001184.
PMID: 36537977 - 22
Effect of exercise training on clinical and physiological variables in adults with myotonic dystrophy type 1: A systematic review protocol.
Shetty S, Luo Y, Thomas A, et al.
MethodsX 2024; (13()):102957 doi:10.1016/j.mex.2024.102957.
PMID: 39376683 - 23
Life expectancy and causes of death in patients with Myotonic Dystrophy Type 2.
Damen MJ, Muilwijk OG, Olde Dubbelink TB, et al.
Journal of neuromuscular diseases 2024; (11(6)):1221-1228 doi:10.3233/JND-240089.
PMID: 39240646 - 24
Risk of Cardiac Disease in a Population-Based Cohort of Myotonic Dystrophy Type 1 and Type 2 in the United States.
Johnson NE, Bhandaru V, Andrews JG, et al.
Neurology. Genetics 2025; (11(6)):e200322 doi:10.1212/NXG.0000000000200322.
PMID: 41170323 - 25
Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.
McNally EM, Mann DL, Pinto Y, et al.
Journal of the American Heart Association 2020; (9(4)):e014006 doi:10.1161/JAHA.119.014006.
PMID: 32067592 - 26
Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis.
Johnson NE, Abbott D, Cannon-Albright LA
Muscle & nerve 2015; (52(4)):659-61 doi:10.1002/mus.24766.
PMID: 26172955 - 27
Palliative Care Need and Quality of Life Mediated by Psychological Distress in Neurologic Diseases.
Chan LML, Choi EPH, Lam WWT, et al.
Journal of pain and symptom management 2025; (69(6)):641-653.e3 doi:10.1016/j.jpainsymman.2025.03.004.
PMID: 40081623 - 28
Comparison of the quality of Nurse-Led palliative care with standard medical care during six months in 405 patients with Parkinson's disease and burdens of their Caregivers: A retrospective study at a single center in China.
Fu S, Sima X, Duan L, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024; (121()):53-60 doi:10.1016/j.jocn.2024.01.027.
PMID: 38359650 - 29
[Multiorgan manifestations in myotonic dystrophy type 1].
Varga D, Pál E
Orvosi hetilap 2019; (160(37)):1447-1454 doi:10.1556/650.2019.31505.
PMID: 31495190 - 30
Health system related kidney supportive care interventions for adults with chronic kidney disease: A systematic review.
Dharmagunawardene D, Kularatna S, Halahakone U, et al.
Journal of renal care 2025; (51(1)):e12517 doi:10.1111/jorc.12517.
PMID: 39639604 - 31
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, et al.
Medicina clinica 2019; (153(2)):82.e1-82.e17 doi:10.1016/j.medcli.2018.10.028.
PMID: 30685181 - 32
Palliative Care Consultation Reduces Heart Failure Transitions: A Matched Analysis.
Diop MS, Bowen GS, Jiang L, et al.
Journal of the American Heart Association 2020; (9(11)):e013989 doi:10.1161/JAHA.119.013989.
PMID: 32456514
This page provides educational information about palliative care for myotonic dystrophy. It does not replace professional medical advice. Always discuss care options and symptom management with your neurologist and healthcare team.
Get notified when new evidence is published on Myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.